Related Experiment Video
Updated: Jun 10, 2026

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
Public data homogenization for AI model development in breast cancer
Vassilis Kilintzis1, Varvara Kalokyri2, Haridimos Kondylakis2
1Institute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Crete, Greece. billyk@ics.forth.gr.
European Radiology Experimental
|April 8, 2024
Summary
This study created the largest homogenized public dataset for breast cancer AI development. The RV-Cherry-Picker platform offers unified access to clinical and imaging data, simplifying AI model creation.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Medicine
- Oncology Imaging
Background:
- Developing trustworthy AI for clinical use necessitates robust data. Publicly available datasets, like those from The Cancer Imaging Archive (TCIA), offer potential but require harmonization due to heterogeneity.
- Breast cancer research benefits from accessible imaging and clinical data, yet existing archives are difficult to filter for specific AI model development needs.
Purpose of the Study:
- To develop a homogenized dataset for breast cancer, integrating clinical and imaging data for AI model development.
- To create a searchable platform for accessing and filtering breast cancer imaging and clinical data.
Main Methods:
- Acquired and harmonized five datasets from TCIA.
- Developed a common data model and an extract-transform-load process for clinical data homogenization.
- Extracted and made searchable Digital Imaging and COmmunications in Medicine (DICOM) information from magnetic resonance imaging (MRI) data.
Main Results:
- Created a homogenized dataset comprising data from 2,035 breast cancer subjects.
- Developed the RV-Cherry-Picker platform for unified searching and downloading of clinical and imaging datasets.
- Enabled selection of specific imaging series (e.g., dynamic contrast-enhanced) for AI model development.
Conclusions:
- RV-Cherry-Picker provides access to the largest, publicly available, homogenized imaging and clinical dataset for breast cancer AI development.
- The presented methodology facilitates the creation of merged public datasets for AI model development, exemplified by breast cancer MRI data.
- The platform offers unified access and detailed selection of breast MRI data, significantly aiding AI model development.
Related Concept Videos
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

